- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Life Science & Biotech
Dow AgroSciences' revenue, profit fall on lower crop prices
October 22, 2009
Dow AgroSciences, the local subsidiary of Midland, Mich.-based Dow Chemical Co., said Thursday that revenue fell 20 percent
and profits plummeted in the third quarter due largely to lower crop commodity prices.
MoreZimmer profits fall, but beat expectations
October 22, 2009
J.K. WallThe Warsaw-based company recorded a third-quarter profit of $150 million, down 30 percent from the same quarter a year ago.
MoreCook: Tax could kill 1,000 jobs in Bloomington
October 21, 2009
J.K. WallBloomington-based Cook Group Inc. could find itself cutting as many as 1,000 local jobs if Congress enacts a tax on
medical devices to pay for health care reform, company founder Bill Cook said in an interview.
MoreState's health IT groups seek stimulus funds
October 16, 2009
Some of Indiana's leading organizations in health information technology are collaborating on an effort to receive several
million dollars of stimulus funding.
MoreDow AgroSciences ratcheting up biotech efforts
October 10, 2009
Scott OlsonDow AgroSciences' introduction of a promising new product is helping transform the Indianapolis company as it transitions
from a focus on traditional agricultural chemicals to genetically altered seeds. The subsidiary of Michigan-based Dow Chemical
Co. partnered with St. Louis-based Monsanto Co. to develop what could become its biggest blockbuster, a genetically modified
corn variety it calls SmartStax.
MoreIndiana life sciences leaders discover dozens of tiny outsourcing companies
October 10, 2009
Chris O'MalleyBioCrossroads, an Indianapolis-based not-for-profit, is cataloging Indiana businesses offering contract services to pharmaceutical
and biotechnology companies, and discovering many small firms operating in relative obscurity.
MoreDow Agro to become Purdue research tenant
September 30, 2009
Officials of Purdue University and Dow AgroSciences unveiled a collaboration Wednesday in which the Indianapolis-based company
will become one of the largest tenants at the Purdue Research Park in West Lafayette.
MoreLilly's win in Evista patent case crucial, analyst says
September 24, 2009
Scott OlsonA decision by a federal judge in Indianapolis to turn back a patent challenge to Eli Lilly and Co.'s Evista marks a major
victory for the company, says an analyst who closely follows the pharmaceutical industry.
MoreJudge upholds Lilly's Evista patent
September 24, 2009
J.K. WallA federal judge in Indianapolis turned back a patent challenge to Eli Lilly and Co.’s drug Evista, the company announced
late yesterday.
MoreLilly Endowment funds OrthoWorx effort with $7 million
September 23, 2009
J.K. WallA new group expected to develop the orthopedic implants industry in Warsaw will be able to proceed now that Indianapolis-based
Lilly Endowment Inc. is putting $7 million behind it, according to an announcement this morning.
MoreLilly reorganization to cut 5,500 positions over 2 years
September 14, 2009
J.K. WallEli Lilly and Co. will cut 5,500 jobs by the end of 2011 as it tries to cut $1 billion in expenses before it loses revenue
from its bestselling drug, Zyprexa. Lilly CEO John Lechleiter said he did not know how many of those cuts would occur in central
Indiana. But with
13,600 employees working in the Indianapolis area, he acknowledged the largest chunk of reductions likely would come here.
MoreMedical device developer receives $1M in federal funding
September 10, 2009
Scott OlsonIndianapolis-based FAST Diagnostics, a developer of a method to quickly measure kidney function, announced today that it has
received $1 million in federal funding.
MoreBioCrossroads rolls out orthopedic initiative
September 10, 2009
J.K. WallWith job growth surging in Warsaw's orthopedic cluster, the life sciences development group BioCrossroads Inc. set out to...
MoreSweetener company Heartland looks for openings in crowded field
September 5, 2009
Kathleen McLaughlinHeartland Sweeteners LLC is now a top maker of private-label alternatives to Splenda. The company also
markets its own products directly to consumers.
MoreExiting AgroSciences chief shook up strategy, culture
August 29, 2009
Greg AndrewsJerome Peribere shifted Dow AgroScience’s focus toward what he calls “revolutionary solutions."
MoreINpact Medical Device Network matches start-ups with service providers
August 24, 2009
Chris O'MalleyIndustry groups in the life sciences, medical and information technology realms have helped lure companies to the region
and foster upstarts. Funding is almost always an issue, but it’s not the only barrier. Getting medical
devices to market often requires product design, development and marketing resources that aren’t
always apparent to upstarts.
MoreRon Henriksen has accumulated a lifetime of mergers and acquisitions
August 17, 2009
Marc D. AllanA light touch and an eye for detail have brought Ron Henriksen riches and adventure in a humble life of deal-making. And at
age 70, he has no plans to stop.
MoreTenants trickling in to Purdue’s technology center
August 17, 2009
Chris O'MalleyFor a city feverishly growing its technology and life sciences sectors, it seemed a bit anticlimactic last January when
Purdue University dedicated its new technology center with only one tenant. But the lone tenant in the $12.8
million complex, FlamencoNets, a high-tech telecommunications firm, is about to get some company.
MoreAbatement approval paves way for Covance jobs
August 12, 2009
Scott OlsonThe Hancock County Council this morning unanimously approved a tax-incentive agreement that should lead Covance Inc. to add
315 jobs at its Greenfield Laboratories.
MoreCook predicts blockbuster with new stent
August 12, 2009
J.K. WallBloomington-based Cook Medical has won European approval for a new artery-opening device for the legs that it predicts will
be a blockbuster.
MoreEmerging life sciences companies grabbing more in government grants
August 10, 2009
Chris O'MalleyMore emerging life science companies have found life in the form of federal
Small Business Innovation Research grants.
MorePOWER BREAKFAST: Panel applauds progress, identifies challenges
August 10, 2009
IBJ StaffA panel of five leaders of the state’s life sciences
industry took on a wide range of topics
July 24 at IBJ’s Power Breakfast
at the Westin Indianapolis.
MoreLilly's Effient launch just one of its many challenges
August 3, 2009
Greg AndrewsEli Lilly and Co. has blasted past analysts’ earnings projections for two straight quarters. But if Lilly officials
take that as a sign they can breathe easier, they need only flip through a stack of Wall Street research reports on the company.
MoreLilly software spinoff Maaguzi sells for $11 million
August 3, 2009
Chris O'MalleyInvestors in a company built around clinical research software bought from Eli Lilly and Co. have found their exit, though
it’s far from the lucrative payoff they’d once imagined.
MoreDow Chemical seems poised to keep AgroSciences
August 3, 2009
Peter SchnitzlerMidland, Mich.-based Dow Chemical Co. is still considering divesting Indianapolis subsidiary Dow AgroSciences LLC. But
chances that the chemical manufacturing giant will sell its local agricultural chemical and biotech unit appear to have decreased.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Saw the Indy Men's Chorus "Music of Gilbert & Sullivan" at the Indiana Historical Society on Sunday evening.
Temporary workers are not "tools" they are people and companies that keep large amounts of temp staff are cheating.
I miss having them around. I hope one of their stores is in the general Meridian/86th Street area. I will make good use of it.
The Fringe! Plus, the simple fact that there are so many local faves in such close proximity to each other.
I remenber, watching the toll road, being built, through South Bend, when I was 10 years old. I believe, back then that it was estimated, that the toll road, would be paid for in 20 years and then it would be free. I am now 71, what happened? Since the power is in the people, by that, I mean that, we the people are in total control of everything. I, suggest that no one ever use the toll road again, let it go broke. We the people can control the price of everything, from groceries to gas, if we would just do it. If we don't pay the asking price, the sellers will lower the price and if we wait awhile, they will lower the price to what we accept as reasonable. I would like to know why a highway like interstate 94, is so well maintained, a much better highway, than the toll road, but has no tolls. I would also like to know why, a sitting governor, with a term limit, maximum of eight years, can lease, public property, for 75 years. Even though I have transponders in both of my trucks and will not be affected by the increase, I have been and will contine to avoid using the toll road. I make many trips from northern Indiana to Chicago, every year, and I prefer the better highway, I94!